NH102
/ Jiangsu NHWA Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
January 08, 2026
Multiple Ascending Dose Study of NH102 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=40 | Completed | Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.
New P1 trial • CNS Disorders • Depression • Mood Disorders • Psychiatry
December 02, 2025
NH102-21: A Phase II Study to Evaluate NH102 for Depression
(clinicaltrials.gov)
- P2 | N=243 | Completed | Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. | Recruiting ➔ Completed | Trial completion date: Mar 2026 ➔ Sep 2025 | Trial primary completion date: Dec 2025 ➔ Jul 2025
Trial completion • Trial completion date • Trial primary completion date • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
February 24, 2025
NH102-21: A Phase II Study to Evaluate NH102 for Depression
(clinicaltrials.gov)
- P2 | N=240 | Recruiting | Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.
New P2 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
February 19, 2025
Single Ascending Dose Study of NH102 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=55 | Completed | Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. | Recruiting ➔ Completed
Trial completion • CNS Disorders • Depression • Mood Disorders • Psychiatry
1 to 4
Of
4
Go to page
1